Srra stock zacks

Jan 3, 2020 $ALSN 4 sec ago: Allison Transmission Lowered to Sell at Zacks Investment Research: Allison Transmission was downgraded by Zacks  Historical daily share prices for Apricus Biosciences since 1999 adjusted for splits and dividends. The latest closing price for Apricus Biosciences as of September 04, 2018 is 0.28. ProNAi Therapeutics (SRRA), Canada, $0.131B, 0.00.

Implied Volatility Surging for Verastem (VSTM) Stock Options - www.zacks.com Secondary Offering Review Week June 8minus 15 Vstm Srra - seekingalpha. CAF, 2020-01-02, MORGAN STANLEY CHINA A SHARE. CAG, 2020-01-02, CONAGRA CVY, 2020-01-02, INVESCO ZACKS MULTI-ASSET IN. CW, 2020-01-02 SRRA, 2020-01-02, SIERRA ONCOLOGY INC. SRRK, 2020-01-02  This free stock trading calculator tool will help you calculate how much dollar Cytori Therapeutics Inc. Series S Warrant — CYTXZ; Invesco Zacks Mid-Cap — CZA Sierra Oncology Inc. — SRRA; Scholar Rock Holding Corporation — SRRK  4 days ago The stock traded as high as $0.39 and last traded at $0.38, 819926 Zacks Investment Research raised shares of Sierra Oncology from a  2549, Sierra Oncology, Inc. Common Stock, SRRA, 14 to purchase one Class A-1 Common Stock at an exercise price of $1, ACEL+, TXN3-2, Y, Tape A. 2549, Sierra Oncology, Inc. Common Stock, SRRA, 14 to purchase one Class A-1 Common Stock at an exercise price of $1, ACEL+, TXN3-2, Y, Tape A.

Get today's Sierra Oncology Inc stock price and latest SRRA news as well as Sierra Oncology real-time stock quotes, technical analysis, full financials and more.

2549, Sierra Oncology, Inc. Common Stock, SRRA, 14 to purchase one Class A-1 Common Stock at an exercise price of $1, ACEL+, TXN3-2, Y, Tape A. 2549, Sierra Oncology, Inc. Common Stock, SRRA, 14 to purchase one Class A-1 Common Stock at an exercise price of $1, ACEL+, TXN3-2, Y, Tape A. 2 days ago Oncology Inc (NASDAQ:SRRA) will announce earnings of ($0.10) per share for the current quarter, according to Zacks Investment Research. Jan 2, 2020 The stock traded as high as $5.55 and last traded at $5.51, approximately Sierra Oncology (NASDAQ:SRRA) Shares Up 8.8% · Aevi Genomic Medicine Synchronoss Technologies (NASDAQ:SNCR) Stock Price Up 16%. Dec 10, 2019 Sierra Oncology Inc (NASDAQ:SRRA) traded down 13.6% during trading on Tuesday . The company traded as low as $0.43 and last traded at 

Get breaking news and analysis on Sierra Oncology, Inc. (SRRA) stock, price quote and chart, trading and investing tools.

The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise  SGMO: Get the latest Sangamo Therapeutics stock price and detailed information At The ASH 2019 Annual Meeting: AXLA, CBMG, SRRA, EPZM, STOK. Sierra Oncology is an ambitious clinical stage drug development company, advancing targeted therapies for treating cancer patients.

Dec 10, 2019 Sierra Oncology Inc (NASDAQ:SRRA) traded down 13.6% during trading on Tuesday . The company traded as low as $0.43 and last traded at 

View ProNAi Therapeutics, Inc. SRRA investment & stock information. Get the latest ProNAi Therapeutics, Inc. SRRA detailed stock quotes, stock data,  SRRA: ProNAi Therapeutics, Inc. broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. Mar 3, 2017 Use the Zacks Rank and Style Scores to find out is SRRA is right for your Zacks Research » ProNAi Therapeutics, Inc. (SRRA) Style Scores  Exploring Sierra Oncology (NASDAQ:SRRA) stock? View SRRA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at  Technical stock forecast for SRRA: Several short-term signals, along with a general good 30 day high of the SRRA stock price was $0.49 and low was $0.30. Sierra Oncology Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Sierra Oncology Inc (SRRA) a buy, sell or hold value for each study, depending on where the price lies in reference to the common interpretation of the study.

The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise 

Get today's Sierra Oncology Inc stock price and latest SRRA news as well as Sierra Oncology real-time stock quotes, technical analysis, full financials and more. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise  SGMO: Get the latest Sangamo Therapeutics stock price and detailed information At The ASH 2019 Annual Meeting: AXLA, CBMG, SRRA, EPZM, STOK. Sierra Oncology is an ambitious clinical stage drug development company, advancing targeted therapies for treating cancer patients. Apr 26, 2019 Sierra Oncology, Inc. (NASDAQ:SRRA) shareholders should be happy to see the share price up 18% in the last quarter. But that is meagre 

Jan 2, 2020 The stock traded as high as $5.55 and last traded at $5.51, approximately Sierra Oncology (NASDAQ:SRRA) Shares Up 8.8% · Aevi Genomic Medicine Synchronoss Technologies (NASDAQ:SNCR) Stock Price Up 16%. Dec 10, 2019 Sierra Oncology Inc (NASDAQ:SRRA) traded down 13.6% during trading on Tuesday . The company traded as low as $0.43 and last traded at  Get today's Sierra Oncology Inc stock price and latest SRRA news as well as Sierra Oncology real-time stock quotes, technical analysis, full financials and more.